SV
Sivasankaran Vinitha
About Sivasankaran Vinitha
Data last updated:
Sivasankaran Vinitha is a Partner at Healfinity Healthcare Llp (since 2025) and Director at Myai Research Labs Private Limited (since 2024). The companies operate in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Healfinity Healthcare Llp ABA-0006 | Partner | 29 May 2025 | 2021 | Active | |
| Myai Research Labs Private Limited U62099PN2024PTC236787 | Director | 31 Dec 2024 | 2024 | Active |
Board colleagues of Sivasankaran Vinitha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Santosh Vishwanath Channa | 06896010 | Healfinity Healthcare Llp | Designated Partner |
| Snehal Prabhu Kosale | 09446770 | Healfinity Healthcare Llp | Designated Partner |
| Mehar Sherim Korambirakkal | 07563150 | Myai Research Labs Private Limited | Director |
| Sahal Thottiyan | 10892527 | Myai Research Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sivasankaran Vinitha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sivasankaran Vinitha
Sivasankaran Vinitha currently holds 2 directorships: Healfinity Healthcare Llp (Partner, since 29 May 2025); Myai Research Labs Private Limited (Director, since 31 Dec 2024).
Sivasankaran Vinitha was first appointed on 31 Dec 2024 as Director at Myai Research Labs Private Limited. The most recent appointment on record is 29 May 2025 at Healfinity Healthcare Llp.
The current boards of Sivasankaran Vinitha's companies include Santosh Vishwanath Channa (Healfinity Healthcare Llp), Snehal Prabhu Kosale (Healfinity Healthcare Llp), Mehar Sherim Korambirakkal (Myai Research Labs Private Limited), Sahal Thottiyan (Myai Research Labs Private Limited).